Vote Scores
Filings read through

West Pharmaceutical Services, Inc.: how funds voted at the meeting of 23 Apr 2024

Ticker
WST
Meeting
Season
year to 30 June 2024
Filers reporting
930
Ballot items
7

930 filers on Form N-PX reported votes at the West Pharmaceutical Services, Inc. meeting of 23 Apr 2024. The records fall into 7 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2024. The latest season on file is the year to 30 June 2026. The page of West Pharmaceutical Services, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2024. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    11 nominees. 93.7% of the reported votes are for. 70 filers withheld from or voted against at least one nominee.

    7,915 vote records from 292 filers. 5 of the 290 filers that marked the item voted against management. 2 filers gave no management mark.

    One filer reported a share count too large for the holding. The site publishes no share split for this item. The rule

    • Positions of 52 fund families
    • For 52
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    1,491 vote records from 915 filers. 65 of the 884 filers that marked the item voted against management. 31 filers gave no management mark.

    2 filers reported share counts too large for the holding. The site publishes no share split for this item. The rule

    • Positions of 55 fund families
    • For 53
    • Against 1
    • Split or no vote 1
    • Against management 1
  3. Item 3: Audit-related items (auditor ratification)

    716 vote records from 290 filers. 12 of the 288 filers that marked the item voted against management. 2 filers gave no management mark.

    One filer reported a share count too large for the holding. The site publishes no share split for this item. The rule

    • Positions of 52 fund families
    • For 51
    • Against 1
    • Against management 1
  4. Item 4: SHAREHOLDER RIGHTS AND DEFENSES: management items

    The company's items in this category are shown together, because filers word and number them differently.

    198 vote records from 39 filers. 2 of the 38 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 12 fund families
    • For 12
    • Against management 1
  5. Item 5: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    1,262 vote records from 262 filers. 1 of the 260 filers that marked the item voted against management. 2 filers gave no management mark.

    One filer reported a share count too large for the holding. The share split leaves those figures out; the counts of filers keep them. The rule

    • Positions of 46 fund families
    • For 46
  6. Item 6: Shareholder Proposal Entitled "Simple Majority Vote"

    632 vote records from 268 filers. 191 of the 268 filers that marked the item voted against management.

    One filer reported a share count too large for the holding. The site publishes no share split for this item. The rule

    • Positions of 50 fund families
    • For 36
    • Against 14
    • Against management 37
  7. Item 7: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    59 vote records from 16 filers. 5 of the 16 filers that marked the item voted against management.

    • Positions of one fund family
    • Against 1

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at West Pharmaceutical Services, Inc., meeting of 23 Apr 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor6. Proposal
AllianceBernsteinForForFor, against management
AllspringForForFor, against management
American CenturyForForFor, against management
Artisan PartnersForForFor, against management
BairdForNo reportNo report
BlackRock and iSharesForForNo report
BNY MellonForForAgainst
Brighthouse FundsForForAgainst, against management
Capital Group and American FundsSplitNo reportNo report
Charles SchwabForForAgainst
Columbia ThreadneedleForForFor, against management
DimensionalForForFor, against management
DWSForForFor, against management
EquitableForForFor, against management
Federated HermesForForAgainst
FidelityForForFor, against management
First TrustForForFor, against management
Franklin TempletonForForAgainst
Global XAgainst, against managementForNo report
Goldman SachsForForFor, against management
Guggenheim and RydexForForFor, against management
Harbor FundsForForFor, against management
Hartford FundsForForAgainst
InvescoForForFor, against management
J.P. MorganForForFor, against management
Jackson National fundsForForFor, against management
Janus HendersonForNo reportNo report
John Hancock and ManulifeForForFor, against management
Lincoln FinancialForForFor, against management
Lord AbbettForForFor, against management
Macquarie and Delaware FundsForForFor, against management
MassMutualForForFor, against management
MFSForForFor, against management
Morgan Stanley, Eaton Vance and CalvertForForFor, against management
NationwideForForFor, against management
Natixis and Loomis SaylesForForFor, against management
Neuberger BermanForForAgainst
Northern Trust and FlexSharesForForFor, against management
Nuveen and TIAAForForFor, against management
Pacific Life fundsForForFor, against management
PGIM and PrudentialForForAgainst
PIMCOForAgainst, against managementFor, against management
PrincipalForForFor, against management
ProShares and ProFundsForForFor, against management
Russell InvestmentsForForAgainst
SEIForForAgainst
State Street and SPDRForForFor, against management
T. Rowe PriceForForAgainst
ThriventForForFor, against management
TransamericaForForAgainst
VanguardForForAgainst
Victory CapitalForForFor, against management
VirtusForForAgainst
VoyaForForFor, against management
WisdomTreeForForFor, against management

Questions

How many filers reported votes at the West Pharmaceutical Services, Inc. meeting?
930 Form N-PX filers reported votes at the meeting of 23 Apr 2024. On say-on-pay, 65 of 884 filers that marked the item voted against management (7.4%). The filings show one separate proposal from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. West Pharmaceutical Services, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list West Pharmaceutical Services, Inc. with a meeting date within three days of 23 Apr 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .